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The insulin-receptor (IR) gene playsa critical role in allowing cells torespond to insulin (1), and insulin
resistance is a prominent feature of non-
insulin-dependent diabetes mellitus
(NIDDM; 2). The involvement of the IR
defects in the etiology of diabetes melli-
tus has been suggested by the findings of
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mutations in the IR gene in rare patients
with genetic syndromes of severe insulin
resistance (3-12). Odawara et al. (7)
have described a case of young Japanese
male with insulin resistance and acan-
thosis nigricans in which valine is sub-
stituted for glycine at position 996 (GTC
instead of GGC) in the tyrosine kinase
domain of the IR gene. Whether this
mutation also contributes to the etiology
of the common forms of NIDDM is un-
known. Therefore, we determined the
prevalence of the Valg96 allele of the IR
gene in a population of white NIDDM
patients.
We studied a population of 103
NIDDM patients referred to the Diabetic
Clinic of our Medical School. Diagnosis
of NIDDM was made according to Na-
tional Diabetes Data Group criteria. All
subjects gave their informed consent to
participate in the study. Subjects had a
mean ± SE age of 56.9 ± 1.06 yr and a
body mass index of 28.12 ± 0.45 kg/m2.
Their diabetes duration was 12.97 ±
0.85 yr. Forty-three were men and 60
were women. We used a modification of
the polymerase chain reaction (PCR)
procedure that permits the rapid identi-
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fication of mutations at sites not recog-
nized by restriction endonucleases (13).
We altered the sequence of the sense
primer such that amplification of DNA
containing a G, but not any other nucle-
otide, at position 3116 of the 1R gene,
would generate a recognition site for the
enzyme Msp I. This region was amplified
as follows: 200 ng of genomic DNA from
each patient were amplified in 50 |xl of
PCR buffer (10 mM Tris-HCl [pH 8.3],
1.5 mM MgCl2, 50 mM KC1, 0.001%
gelatin) containing 20 pmol of each oli-
gonucleotide primer (nucleotides 3089
to 3115, sense strand; nucleotides 3191
to 3217, antisense strand) and 10 nmol
of each deoxyribonucleotide triphos-
phate; one unit of thermus aquaticus
DNA polymerase (Perkin Elmer Cetus,
Norwalk, CT) was added and 100 p-l of
mineral oil was layered over the samples.
The samples were incubated at 95, 55,
and 72°C, respectively, for 45, 50, and
50 s; this cycle was performed 36 times
in a DNA-RNA amplifier (Biostar Violet,
Rome, Italy). The amplified DNAs were
restricted with Msp I and analyzed by
electrophoresis in 2.5% agarose.
Because all the DNAs were di-
gested by Msp I showing the presence of
a G at position 3116 of the IR gene, we
never detected Val996 allele in our dia-
betic patients.
Our data are consistent with a
very low prevalence of the Val996 allele of
the IR gene (< 1/206 alleles) in the
NIDDM population. Further studies are
needed to establish the prevalence of
other IR gene mutations among diabetic
individuals.
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